US Broker Ratings

Sanofi (SNY) Stock Analysis: Evaluating a 27% Upside Potential in Healthcare Giant

Sanofi (NASDAQ: SNY), a stalwart in the healthcare sector, continues to capture investor attention with its promising 27% potential upside. As a global leader in drug manufacturing, Sanofi is headquartered..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 30.96% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing opportunity for investors with its strong position in the healthcare sector, particularly in the medical devices industry. Headquartered in Chicago, Illinois,..

CVS Health Corporation (CVS) Stock Analysis: Navigating Growth with a Forward P/E of 12.80

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, boasting a market capitalization of $137.47 billion. As a leader in healthcare plans within the United..

Cardinal Health (CAH) Stock Analysis: Navigating a 10.69% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a heavyweight in the healthcare sector, is drawing attention from investors with its promising potential upside of 10.69%. As a key player in the medical..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 16.25% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a titan in the biotechnology sector, continues to capture investor attention with its promising pipeline and robust market presence. As of the latest trading session,..

GSK plc (GSK) Stock Analysis: Evaluating a 13.10% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector with a market capitalization of $102.84 billion, commands significant attention from investors worldwide. Known for its robust portfolio of vaccines,..

The Cigna Group (CI) Investor Outlook: Strong Buy Ratings and a 17.73% Potential Upside

Investors keeping an eye on the healthcare sector should take note of The Cigna Group (CI), a giant in the healthcare plans industry with a market cap of $76.6 billion...

Elevance Health, Inc. (ELV) Stock Analysis: Exploring an 18.91% Potential Upside

Elevance Health, Inc. (NYSE: ELV), previously known as Anthem, Inc., stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of..

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Growth Potential and Analyst Ratings

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to captivate investors with its robust market presence and substantial growth prospects. With a market capitalization of $634.77..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant with a 17% Potential Upside

For investors seeking a stable yet promising player in the healthcare sector, Stryker Corporation (NYSE: SYK) presents a compelling opportunity. As a leading entity in the medical devices industry, Stryker’s..

Gilead Sciences, Inc. (GILD) Stock Analysis: Unveiling a 21.81% Potential Upside for Investors

Investors eyeing Gilead Sciences, Inc. (NASDAQ: GILD) may find themselves intrigued by the stock’s current positioning within the healthcare sector, particularly the drug manufacturing industry. With a robust market capitalization..

Eli Lilly (LLY) Stock Analysis: Uncovering Growth Potential in the Healthcare Behemoth

Eli Lilly and Company (NYSE: LLY) stands as a formidable force in the healthcare sector, boasting a staggering market capitalization of $1.07 trillion. This pharmaceutical giant, headquartered in Indianapolis, Indiana,..

Standard BioTools Inc. (LAB) Stock Analysis: Is a 77% Upside Within Reach?

Standard BioTools Inc. (NASDAQ: LAB), a key player in the medical devices sector, is drawing attention from investors with a noteworthy potential upside of 77.08%. As a company that provides..

Kamada Ltd. (KMDA) Stock Analysis: Exploring an 86.78% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents a compelling case with its robust product portfolio and significant potential upside. The Israeli-based company, specializing in..

Celcuity Inc. (CELC) Investor Outlook: Analyzing an 85% Upside Potential in the Biotech Sector

Celcuity Inc. (NASDAQ: CELC) is capturing the attention of investors with its promising potential upside of 85%, as indicated by current analyst ratings. As a clinical-stage biotechnology company focused on..

Inventiva S.A. (IVA) Stock Analysis: Unpacking the 235% Potential Upside

Inventiva S.A. – American Depositary Shares (IVA) is catching the eye of the investment community, especially considering its massive potential upside of 235.38%. This French biotechnology company, with a market..

Abivax SA (ABVX): Investor Outlook on a Biotech with 23% Potential Upside

Abivax SA (ABVX), a French biotechnology company, is capturing investor attention with its innovative approach to treating chronic inflammatory diseases. With a market capitalization of $11.43 billion, Abivax is a..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring the 170% Upside Potential in Biotech Innovation

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a prominent player in the biotechnology sector, is stirring considerable interest among investors with its potential for substantial upside. With a market capitalization of $1.15..

Auna SA (AUNA)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds